27802237|t|Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.
27802237|a|BACKGROUND: Alzheimer's disease (AD) is associated with progressive impairments in brain insulin, insulin-like growth factor (IGF), and insulin receptor substrate (IRS) signaling through Akt pathways that regulate neuronal growth, survival, metabolism, and plasticity. The intracerebral streptozotocin (i.c. STZ) model replicates the full range of abnormalities in sporadic AD. T3D-959, an orally active PPAR-delta/gamma agonist remediates neurocognitive deficits and AD neuropathology in the i.c. STZ model. OBJECTIVE: This study characterizes the effects of T3D-959 on AD biomarkers, insulin/IGF/IRS signaling through Akt pathways, and neuroinflammation in an i.c. STZ model. METHODS: Long Evans rats were treated with i.c. STZ or saline, followed by daily oral doses of T3D-959 (1 mg/kg) or saline initiated 1 day (T3D-959-E) or 7 days (T3D-959-L) later through Experimental Day 28. Protein and phospho-protein expression and pro-inflammatory cytokine activation were measured in temporal lobe homogenates by duplex or multiplex bead-based ELISAs. RESULTS: i.c. STZ treatments caused neurodegeneration with increased pTau, AbetaPP, Abeta42, ubiquitin, and SNAP-25, and reduced levels of synaptophysin, IGF-1 receptor (R), IRS-1, Akt, p70S6K, mTOR, and S9-GSK-3beta. i.c. STZ also broadly increased neuroinflammation. T3D-959 abrogated or reduced most of the AD neuropathological and biomarker abnormalities, increased/normalized IGF-1R, IRS-1, Akt, p70S6K, and S9-GSK-3beta, and decreased expression of multiple pro-inflammatory cytokines. T3D-959-E or -L effectively restored insulin/IGF signaling, whereas T3D-959-L more broadly resolved neuroinflammation. CONCLUSION: AD remediating effects of T3D-959 are potentially due to enhanced expression of key insulin/IGF signaling proteins and inhibition of GSK-3beta and neuroinflammation. These effects lead to reduced neurodegeneration, cognitive impairment, and AD biomarker levels in the brain.
27802237	23	26	IGF	Gene	24482
27802237	49	66	Neuroinflammation	Disease	MESH:D000090862
27802237	72	79	T3D-959	Chemical	-
27802237	108	116	Sporadic	Disease	MESH:D020821
27802237	117	136	Alzheimer's Disease	Disease	MESH:D000544
27802237	150	169	Alzheimer's disease	Disease	MESH:D000544
27802237	171	173	AD	Disease	MESH:D000544
27802237	236	262	insulin-like growth factor	Gene	24482
27802237	264	267	IGF	Gene	24482
27802237	325	328	Akt	Gene	24185
27802237	425	439	streptozotocin	Chemical	MESH:D013311
27802237	446	449	STZ	Chemical	MESH:D013311
27802237	503	511	sporadic	Disease	MESH:D020821
27802237	512	514	AD	Disease	MESH:D000544
27802237	516	523	T3D-959	Chemical	-
27802237	542	558	PPAR-delta/gamma	Gene	25664
27802237	578	601	neurocognitive deficits	Disease	MESH:D009461
27802237	606	608	AD	Disease	MESH:D000544
27802237	636	639	STZ	Chemical	MESH:D013311
27802237	698	705	T3D-959	Chemical	-
27802237	709	711	AD	Disease	MESH:D000544
27802237	732	735	IGF	Gene	24482
27802237	758	761	Akt	Gene	24185
27802237	776	793	neuroinflammation	Disease	MESH:D000090862
27802237	805	808	STZ	Chemical	MESH:D013311
27802237	836	840	rats	Species	10116
27802237	864	867	STZ	Chemical	MESH:D013311
27802237	911	918	T3D-959	Chemical	-
27802237	956	963	T3D-959	Chemical	-
27802237	978	986	T3D-959-	Chemical	-
27802237	1071	1083	inflammatory	Disease	MESH:D007249
27802237	1203	1206	STZ	Chemical	MESH:D013311
27802237	1225	1242	neurodegeneration	Disease	MESH:D019636
27802237	1258	1262	pTau	Gene	29477
27802237	1264	1271	AbetaPP	Gene	54226
27802237	1297	1304	SNAP-25	Gene	25012
27802237	1328	1341	synaptophysin	Gene	24804
27802237	1343	1357	IGF-1 receptor	Gene	25718
27802237	1363	1368	IRS-1	Gene	25467
27802237	1370	1373	Akt	Gene	24185
27802237	1375	1381	p70S6K	Gene	83840
27802237	1383	1387	mTOR	Gene	56718
27802237	1396	1405	GSK-3beta	Gene	84027
27802237	1412	1415	STZ	Chemical	MESH:D013311
27802237	1439	1456	neuroinflammation	Disease	MESH:D000090862
27802237	1458	1465	T3D-959	Chemical	-
27802237	1499	1501	AD	Disease	MESH:D000544
27802237	1570	1576	IGF-1R	Gene	25718
27802237	1578	1583	IRS-1	Gene	25467
27802237	1585	1588	Akt	Gene	24185
27802237	1590	1596	p70S6K	Gene	83840
27802237	1605	1614	GSK-3beta	Gene	84027
27802237	1657	1669	inflammatory	Disease	MESH:D007249
27802237	1681	1693	T3D-959-E or	Chemical	-
27802237	1726	1729	IGF	Gene	24482
27802237	1749	1756	T3D-959	Chemical	-
27802237	1781	1798	neuroinflammation	Disease	MESH:D000090862
27802237	1812	1814	AD	Disease	MESH:D000544
27802237	1838	1845	T3D-959	Chemical	-
27802237	1904	1907	IGF	Gene	24482
27802237	1945	1954	GSK-3beta	Gene	84027
27802237	1959	1976	neuroinflammation	Disease	MESH:D000090862
27802237	2008	2025	neurodegeneration	Disease	MESH:D019636
27802237	2027	2047	cognitive impairment	Disease	MESH:D003072
27802237	2053	2055	AD	Disease	MESH:D000544
27802237	Positive_Correlation	MESH:D013311	25012
27802237	Positive_Correlation	MESH:D013311	54226
27802237	Association	MESH:D019636	29477
27802237	Association	MESH:D000544	24482
27802237	Positive_Correlation	MESH:D013311	MESH:D019636
27802237	Negative_Correlation	MESH:D013311	83840
27802237	Negative_Correlation	MESH:D013311	MESH:D020821
27802237	Negative_Correlation	MESH:D013311	56718
27802237	Association	MESH:D000544	24185
27802237	Negative_Correlation	MESH:D013311	25467
27802237	Negative_Correlation	MESH:D013311	24185
27802237	Positive_Correlation	MESH:D013311	MESH:D000090862
27802237	Positive_Correlation	MESH:D013311	29477
27802237	Negative_Correlation	MESH:D013311	84027
27802237	Negative_Correlation	MESH:D013311	25718
27802237	Association	MESH:D019636	54226
27802237	Association	MESH:D019636	25012
27802237	Negative_Correlation	MESH:D013311	24804
27802237	Association	MESH:D013311	MESH:D000544

